The risk and severity of developing symptomatic palpitations when prescribed mirabegron for overactive bladder.

Author: BalachandranAswini A, DuckettJonathan R A

Paper Details 
Original Abstract of the Article :
Mirabegron is a new selective β3-adrenoreceptor agonist licensed for the treatment of overactive bladder (OAB). In clinical trials, mirabegron is well-tolerated with a low side-effect profile. There is little data available on the risks in a non-selected population. The presence of β-adrenoreceptors...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ejogrb.2015.02.020

データ提供:米国国立医学図書館(NLM)

Mirabegron for Overactive Bladder: Evaluating the Risk of Palpitations

This research investigates the risk of developing palpitations, a fast or irregular heartbeat, when taking mirabegron, a medication used to treat overactive bladder (OAB). Imagine your bladder as a camel's water pouch. When this pouch becomes overactive and leaks, it can be uncomfortable. Mirabegron helps regulate the pouch, but some people may experience side effects like palpitations. This study aimed to assess the risk of developing palpitations while taking mirabegron and identify any factors that might increase this risk. The researchers conducted a cohort study, following a group of patients with OAB who were prescribed mirabegron. The study's findings will provide valuable information about the potential side effects of mirabegron and help doctors make informed decisions about prescribing this medication.

Mirabegron: Weighing the Benefits and Risks

This research highlights the importance of carefully considering the potential side effects of medications, even those with a generally good safety profile. The findings will help doctors make informed decisions about prescribing mirabegron for overactive bladder, balancing the benefits of treatment with the potential risks for individual patients.

Managing Overactive Bladder: A Journey Through Treatment Options

Overactive bladder can be a common and often embarrassing condition. This study encourages open communication with your doctor to discuss the best treatment options and potential side effects. It's important to find a treatment plan that addresses your individual needs and minimizes potential risks.

Dr.Camel's Conclusion

This study, like a careful camel caravan navigating a desert, underscores the importance of understanding the potential risks and benefits of medications. The findings highlight the importance of open communication between doctors and patients, ensuring informed decision-making and individualized treatment plans.

Date :
  1. Date Completed 2015-12-14
  2. Date Revised 2015-03-27
Further Info :

Pubmed ID

25756594

DOI: Digital Object Identifier

10.1016/j.ejogrb.2015.02.020

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.